2-Pyrones possessing antimicrobial and cytotoxic activities

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 15, 2004, Pages 4285-4299

  Fairlamb, Ian J S ^a   Marrison, Lester R ^b   Dickinson, Julia M ^b   Lu, Feng Ju ^a   Schmidt, Jan Peter ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FORMYLPHENYL) 6 METHYL 2 PYRONE; 4 (4 METHOXYPHENYL) 6 METHYL 2 PYRONE; 4 (4 METHYLPHENYL) 6 METHYL 2 PYRONE; 4 BROMO 6 METHYL 2 PYRONE; 4 BUTYL 6 METHYL 2 PYRONE; 4 ETHYL 6 METHYL 2 PYRONE; 4 ETHYNYL 6 METHYL 2 PYRONE; 4 HEPTENYL 6 METHYL 2 PYRONE; 4 HEPTYL 6 METHYL 2 PYRONE; 4 HEXENYL 6 METHYL 2 PYRONE; 4 HEXYL 6 METHYL 2 PYRONE; 4 OCTENYL 6 METHYL 2 PYRONE; 4 OCTYL 6 METHYL 2 PYRONE; 4 PENTENYL 6 METHYL 2 PYRONE; 4 PENTYL 6 METHYL 2 PYRONE; 4 PHENYL 6 METHYL 2 PYRONE; 4 PHENYLETHENYL 6 METHYL 2 PYRONE; 4 PHENYLETHYL 6 METHYL 2 PYRONE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ORGANOMETALLIC COMPOUND; PYRONE DERIVATIVE; THALLIUM; THALLIUM CARBONATE; UNCLASSIFIED DRUG;

ALKYNYLATION; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; BOTRYTIS CINEREA; CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CROSS COUPLING REACTION; CYTOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; NEGISHI REACTION; NONHUMAN; SCHIZOSACCHAROMYCES POMBE; SONOGASHIRA REACTION; STAPHYLOCOCCUS AUREUS; SUZUKI REACTION;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; CELL DIVISION; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRONES; STRUCTURE-ACTIVITY RELATIONSHIP;

BACILLUS SUBTILIS; BOTRYOTINIA FUCKELIANA; BOTRYTIS; ESCHERICHIA COLI; LATEOLABRAX JAPONICUS; SCHIZOSACCHAROMYCES; SCHIZOSACCHAROMYCES POMBE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 3042791028     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2004.01.051     Document Type: Article

References (75)

1. Staunton J. Burton D.H., Ollis W.D. Comprehensive Organic Chemistry. Vol. IV:1979;629 Pergamon, New York
2. Moreno-Manas M., Pleixats R. Naturally Occurring Oxygen Ring Systems. 1992, Academic, New York. p 21
3. Altomare C., Perrone G., Zonno M.C., Evidente A., Pengue R., Fanti F., Polonelli L. J. Nat. Prod. 63:2000;1131
4. Dickinson J.M. Nat. Prod. Rep. 10:1993;71
5. Uen Y. Purchase I.F.H. Mycotoxins. 1974;283 Elsevier, New York
6. Spencer H.C., Rowe K., McCollister D.D. J. Pharmacol. Exp. Ther. 99:1950;57
7. Tringali C., Parisi A., Piatelli M., Di San Lio G. Nat. Prod. Lett. 3:1993;101
8. Hansen O.R. Acta Chem. Scand. 8:1954;1332
9. Bu'Lock J.D., Smith H.E. J. Chem. Soc. 1:1960;502
10. Effenberger F., Ziegler T. Chem. Ber. 120:1987;1339
11. Tam T.F., Coles P. Synthesis. 1988;383
12. Moody C.J., Rahimtoola K.F. J. Chem. Soc., Perkin Trans. 1. 1990;673
13. Moody C.J., Rahimtoola K.F. J. Chem. Soc., Perkin Trans. 1. 1990;681
14. Afridi A.S., Katritzky A.R., Ramsden C.A. J. Chem. Soc., Perkin Trans. 1. 1977;1428
15. Kiang A.K., Tang S.F., Wang W.S. J. Chem. Soc. 1:1971;2721
16. Lee J.-H., Kim W.-S., Lee Y.Y., Cho C.-G. Tetrahedron Lett. 43:2002;5779
17. Lee J.-H., Park J.-S., Cho C.-G. Org. Lett. 4:2002;1171
18. Cerezo S., Moreno-mañas M., Pleixats R. Tetrahedron. 54:1998;7813
19. Bellina F., Biagetti M., Carpita A., Rossi R. Tetrahedron Lett. 42:2001;2859
20. Marrison L.R., Dickinson J.M., Fairlamb I.J.S. Bioorg. Med. Chem. Lett. 12:2002;3509
21. Marrison L.R., Dickinson J.M., Ahmed R., Fairlamb I.J.S. Tetrahedron Lett. 43:2002;8853
22. Marrison L.R., Dickinson J.M., Ahmed R., Fairlamb I.J.S. Bioorg. Med. Chem. Lett. 13:2003;2667
23. Shi X., Leal W.S., Liu Z., Schrader E., Meinwald J. Tetrahedron Lett. 36:1995;71
24. Leal W.S., Shi X., Liang D., Schal C., Meinwald J. Proc. Natl. Acad. Sci. U.S.A. 92:1995;1033
25. Danieli B., Lesma G., Martinelli M., Passarella D., Peretto I., Silvani A. Tetrahedron. 54:1998;14081
26. Liu Z., Meinwald J. J. Org. Chem. 61:1996;6693
27. Waldmann H. Bioorg. Med. Chem. 11:2003;3045
28. Cervera M., Moreno-mañas M., Pleixats R. Tetrahedron. 46:1990;7885
29. Kato Y., Okada S., Tomimoto K., Mase T. Tetrahedron Lett. 42:2001;4849
30. Negishi E., Anastasia L. Chem. Rev. 103:2003;1979
31. Fairlamb I.J.S., Lu F.-J., Schmidt J.-P. Synthesis. 2003;2564
32. Beletskaya I.P., Cheprakov A.V. Chem. Rev. 100:2000;3009
33. Takia K., Sato M., Oshima A., Nozaki H. Bull. Chem. Soc. Jpn. 57:1984;108
34. Baba S., Negishi E. J. Am. Chem. Soc. 98:1976;6729
35. Miyaura N., Suzuki A. Chem. Commun. 1979;866
36. Negishi E., Valente L.F., Kobayashi M. J. Am. Chem. Soc. 102:1980;3298
37. Hatanaka Y., Ebina Y., Hiyama T. J. Am. Chem. Soc. 113:1991;7075. and references cited therein
38. Stille J.K. Angew. Chem., Int. Ed. Engl. 25:1986;508
39. Negishi E., Takahashi T., Baba S., Van Horn D.E., Okukado N. J. Am. Chem. Soc. 109:1987;2393
40. Negishi E., Van Horn D.E. J. Am. Chem. Soc. 100:1978;2252
41. Negishi E., Okukado N., King A., Spiegel B.I., Van Horn D.E. J. Am. Chem. Soc. 100:1978;2254
42. Miyaura N. J. Organomet. Chem. 653:2002;54
43. Suzuki A. Acc. Chem. Res. 15:1982;178
44. Suzuki A. Pure Appl. Chem. 57:1985;1749
45. Miyaura N., Suzuki A. Chem. Rev. 95:1995;2457
46. Stanforth S.P. Tetrahedron. 54:1998;263
47. Wolfe J.P., Singer R.A., Yang B.H., Buchwald S.L. J. Am. Chem. Soc. 121:1999;9550
48. Wolfe J.P., Buchwald S.L. Angew. Chem., Int. Ed. 38:1999;2413
49. Brown H.C., Gupta S.K. J. Am. Chem. Soc. 97:1975;5249
50. Wailes P.C., Weigold H., Bell A.P. J. Organomet. Chem. 8:1967;239
51. Schwartz J. J. Organomet. Chem. Libr. 1:1976;461
52. Okukado N., Van Horn D.E., Klima W.L., Negishi E. Tetrahedron Lett. 19:1978;1027
53. Brown H.C. Organic Synthesis via Boranes. 1975;New York, Wiley
54. Castle P.L., Widdowson D.A. Tetrahedron Lett. 27:1986;6013
55. Perchellet E.M., Ladesich J.B., Chen Y., Sin H.S., Hua D.H., Kraft S.L., Perchellet J.P. Anticancer Drugs. 1998;565
56. Perchellet J.P., Newell S.W., Ladesich J.B., Perchellet E.M., Chen Y., Hua D.H., Kraft S.L., Basaraba R.J., Omura S., Tomoda H. Anticancer Res. 1:1997;2427
57. A variety of E-chalcones have been reported with potent inhibitory activity against the K562 cell line, see: Ducki S., Forrest R., Hadfield J.A., Kendall A., Lawrence N.J., McGown A.T., Rennison D. Bioorg. Med. Chem. Lett. 8:1998;1051. For references relating to inhibitory activity against the A2780 cell line, see:
58. McClusky A., Bowyer M.C., Collins E., Sim A.T.R., Sakoff J.A., Baldwin M.L. Bioorg. Med. Chem. Lett. 10:2000;1687
59. Kokotos G., Constantinou-Kokotou V., Padrón J.M., Peters G. J. Bioorg. Med. Chem. Lett. 11:2001;861
60. Dufresne C., Wilson K.E., Zink D., Smith J., Bergstrom J.D., Kurtz M., Rew D., Nallin M., Jenkins R., Bartizal K., Trainor C., Bills G., Meinz M., Huang L., Onishi J., Milligan J., Mojena M., Pelaez F. Tetrahedron. 48:1992;10221-10226
61. For complete assay procedures for the 2-pyrones see: Marrison, L. R., Ph.D. Thesis, The synthesis and antimicrobial activities of 2H-pyran-2-ones, (Chapter 5), Manchester Metropolitan University (UK), 1998; Dickinson, J. M., Ph.D. Thesis, The chemistry of fungal biocontrol agents, University of Sussex (UK), 1988
62. Laskin A.I., Lechevailer H.A. CRC Handbook of Microbiology. Organismic Microbiology. Vol. I:1973;CRC, Ohio
63. Hatch M.S., Brown W.M., Deck J.A., Hunsaker L.A., Deck L.M., Vander Jagt D.L. Biochim. Biophys. Acta. 1596:2002;381
64. Deck L.M., Baca M.L., Salas S.L., Hunsaker L.A., Vander Jagt D.L. J. Med. Chem. 42:1999;4250
65. Mann F.G., Purdie D. J. Chem. Soc. 1935;1549
66. Kato Y., Okada S., Tomimoto K., Mase T. Tetrahedron Lett. 42:2001;4849
67. Brown H.C., Gupta S.K. J. Am. Chem. Soc. 94:1972;4370
68. Matteson D.S. Synthesis. 1975;147
69. Dieck H.A., Heck R.F. J. Org. Chem. 40:1975;1083
70. Matteson D.S., Jesthi P.K. J. Organomet. Chem. 10:1976;25
71. Hamaoka T., Brown H.C. J. Org. Chem. 40:1975;1189
72. Matteson D.S. J. Am. Chem. Soc. 97:1975;5608
73. Mossmann T. J. Immunol. Meth. 63:1983;55
74. Edmondson J.M., Armstrong L.S., Martinez A.O. J. Tissue Culture Meth. 11:1988;15
75. 2O to give a final concentration of 200 μg/disk